PMID: 7197208Sep 1, 1981Paper

Perinatal morbidity and mortality in small-for-dates babies: the relative importance of some maternal factors

Early Human Development
M OunstedW A Scott

Abstract

Data on 538 mothers and their small-for-dates babies were analysed to ascertain whether any specific maternal factors were associated with increased perinatal risks. There were 34 deaths; 21 (62%) of these babies had major congenital abnormalities. Among the survivors perinatal morbidity was also markedly increased when the baby was abnormal. No direct associations were found between abnormal babies and any maternal factors. Few differences were found in the incidence of mortality and morbidity factors according to maternal height, weight, weight gain in pregnancy, social class and smoking habits. There was a significantly higher death rate when the mother was pre-eclamptic, and the incidence of seven other morbidity factors was also increased. The only adverse effects of maternal hypertension without pre-eclampsia was a higher instrumental delivery rate, and more of these babies were tube-fed. There were only significantly more perinatal deaths among multiparous women whose previous babies had been of average birthweight. This was due to an excess of congenitally abnormal babies in this group. Only 35% small-for-dates babies escaped any perinatal problems.

References

Oct 1, 1967·The Journal of Obstetrics and Gynaecology of the British Commonwealth·F E Loeffler

❮ Previous
Next ❯

Citations

Jan 30, 1991·European Journal of Obstetrics, Gynecology, and Reproductive Biology·N J SecherP Bagger
Nov 12, 2013·Journal de gynécologie, obstétrique et biologie de la reproduction·L J Salomon, V Malan
Jul 2, 1998·Obstetrics and Gynecology·V K Minior, M Y Divon
Nov 5, 1999·Obstetrics and Gynecology·B ClaussonO Axelsson
Mar 1, 1988·Baillière's Clinical Obstetrics and Gynaecology·P Agustsson, N Patel
Mar 12, 2003·BJOG : an International Journal of Obstetrics and Gynaecology·Euan M WallaceGraham Jenkin
Jan 1, 1992·International Journal of Technology Assessment in Health Care·M Wennergren
Jul 18, 2009·Journal of Perinatology : Official Journal of the California Perinatal Association·S K SrinivasM A Elovitz
Dec 16, 2000·Clinical and Experimental Pharmacology & Physiology·R HardingG S Maritz
Jun 1, 1996·Obstetrical & Gynecological Survey·A Ghidini
Jan 1, 1991·Paediatric and Perinatal Epidemiology·M CuttiniU de Vonderweid
Apr 1, 1991·Paediatric and Perinatal Epidemiology·A W Read, F J Stanley
Jul 1, 1997·Paediatric and Perinatal Epidemiology·P J MeisK A Johns
Sep 1, 1986·Archives of Disease in Childhood·R A Jones, N R Roberton
Apr 30, 2003·Archives of Disease in Childhood. Fetal and Neonatal Edition·B C GallandR M Sayers
Apr 14, 2006·Hormone Research·S M Bryan, P C Hindmarsh
Nov 25, 2003·Pediatric Research·Gert S MaritzRichard Harding
Jan 1, 1988·Journal of Perinatal Medicine·A Tenovuo
May 20, 2014·Seminars in Perinatology·Samantha E Parker, Martha M Werler
Mar 1, 1985·Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN·D Wise, J L Engstrom
Oct 3, 2009·Taiwanese Journal of Obstetrics & Gynecology·Chih-Ping Chen
Jun 1, 1986·Journal of Pediatric Surgery·A W FlakeM R Harrison
Apr 21, 2009·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Barbara M O'Brien
Apr 28, 2006·Acta Neurologica Scandinavica. Supplementum·J DahlN E Gilhus
Oct 26, 2006·Pediatric Pulmonology·Jill LipsettJulie A Owens
Sep 1, 1984·Early Human Development·S CnattingiusG Lindmark
Jan 1, 1988·Acta Paediatrica Scandinavica. Supplement·P Uvebrant
Aug 26, 1998·Obstetrics and Gynecology Clinics of North America·B A Campbell
Mar 1, 1996·Obstetrics and Gynecology Clinics of North America·M Hod, O Langer
Feb 25, 2014·BMC Medicine·Andrew James LewisChristos Symeonides
Feb 17, 2009·American Journal of Obstetrics and Gynecology·Suneet P ChauhanUNKNOWN American College of Obstetricians and Gynecologists
May 17, 2014·European Journal of Obstetrics, Gynecology, and Reproductive Biology·V L KaranamN Anim-Nyame
Aug 12, 2009·Best Practice & Research. Clinical Obstetrics & Gynaecology·Srividhya Sankaran, Phillipa M Kyle
Nov 4, 2004·Journal of Intensive Care Medicine·Dara Brodsky, Helen Christou
May 8, 2001·Hospital Medicine·J Waugh, M Kilby

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.